Indication
Malignant neoplasm of fallopian tube
A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end. Read more about Malignant neoplasm of fallopian tube
1 drugs 1 manufacturers
Drugs that treat it
Common Malignant neoplasm of fallopian tube therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end.
Predominantly affecting postmenopausal women, it shares biological, clinical, and staging characteristics with epithelial ovarian and primary peritoneal cancers.
Pathophysiologically, high-grade serous carcinoma accounts for the majority of cases and frequently harbors alterations in TP53 and pathogenic BRCA mutations.
Clinical manifestations are often subtle or nonspecific, but advanced disease may present with abdominal distension, pelvic pain, abnormal vaginal bleeding or profuse watery discharge, and a pelvic mass.
- cancer.gov
A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end
- nih.gov
A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end Pathophysiologically, high-grade serous carcinoma accounts for the majority of cases and frequently harbors alterations in TP53 and pathogenic BRCA mutations
- pennmedicine.org
A malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial lining of the oviducts, most commonly originating in the fimbriated end Pathophysiologically, high-grade serous carcinoma accounts for the majority of cases and frequently harbors alterations in TP53 and pathogenic BRCA mutations
- ucsfhealth.org
Predominantly affecting postmenopausal women, it shares biological, clinical, and staging characteristics with epithelial ovarian and primary peritoneal cancers Pathophysiologically, high-grade serous carcinoma accounts for the majority of cases and frequently harbors alterations in TP53 and pathogenic BRCA mutations Clinical manifestations are often subtle or nonspecific, but advanced disease may present with abdominal distension, pelvic pain, abnormal vaginal bleeding or profuse watery dischar...
- nih.gov
Predominantly affecting postmenopausal women, it shares biological, clinical, and staging characteristics with epithelial ovarian and primary peritoneal cancers
- stonybrookmedicine.edu
Predominantly affecting postmenopausal women, it shares biological, clinical, and staging characteristics with epithelial ovarian and primary peritoneal cancers
- nih.gov
Clinical manifestations are often subtle or nonspecific, but advanced disease may present with abdominal distension, pelvic pain, abnormal vaginal bleeding or profuse watery discharge, and a pelvic mass
Personalize your experience
Follow Malignant neoplasm of fallopian tube and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.